Ventricular Tachycardia clinical trials at UCSF
3 in progress, 1 open to eligible people
Transseptal vs Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli
open to eligible people ages 18 years and up
This study is a prospective, multicenter, randomized (1:1) controlled comparative effectiveness trial of a transseptal approach to left ventricular ablation compared to a retrograde aortic approach to prevent cerebral emboli and neurocognitive decline in adults with ventricular tachycardia (VT) and/or premature ventricular contractions (PVCs).
San Francisco, California and other locations
Cryoablation for Monomorphic Ventricular Tachycardia Early Feasibility Study (EFS)
Sorry, not yet accepting patients
The objective of this clinical study is to evaluate the safety and performance of the Adagio VT Cryoablation System in the ablation treatment of Sustained Monomorphic VT (SMVT)
San Francisco, California and other locations
IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry
Sorry, accepting new patients by invitation only
This is a prospective multi-center international registry. The objective of this registry is to collect prospective data on patients undergoing catheter ablation for Ventricular Tachycardia (VT) and Premature Ventricular Contractions (PVC). The registry will be used for clinical monitoring, research, and quality improvement purposes.
San Francisco, California and other locations
Our lead scientists for Ventricular Tachycardia research studies include Edward Gerstenfeld, MD Gregory Marcus.
Last updated: